These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29845122)

  • 1. Growth Suppression of Glioma Cells Using HDAC6 Inhibitor, Tubacin.
    Yin C; Li P
    Open Med (Wars); 2018; 13():221-226. PubMed ID: 29845122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition of histone deacetylase 6 (HDAC6) induces DNA damage and sensitizes transformed cells to anticancer agents.
    Namdar M; Perez G; Ngo L; Marks PA
    Proc Natl Acad Sci U S A; 2010 Nov; 107(46):20003-8. PubMed ID: 21037108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HDAC6 activity is not required for basal autophagic flux in metastatic prostate cancer cells.
    Watson GW; Wickramasekara S; Fang Y; Maier CS; Williams DE; Dashwood RH; Perez VI; Ho E
    Exp Biol Med (Maywood); 2016 Jun; 241(11):1177-85. PubMed ID: 26643866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LC3B-II deacetylation by histone deacetylase 6 is involved in serum-starvation-induced autophagic degradation.
    Liu KP; Zhou D; Ouyang DY; Xu LH; Wang Y; Wang LX; Pan H; He XH
    Biochem Biophys Res Commun; 2013 Nov; 441(4):970-5. PubMed ID: 24220335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The histone deacetylase-6 inhibitor tubacin directly inhibits de novo sphingolipid biosynthesis as an off-target effect.
    Siow D; Wattenberg B
    Biochem Biophys Res Commun; 2014 Jul; 449(3):268-71. PubMed ID: 24835950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel HDAC6 inhibitor Tubastatin A: Controls HDAC6-p97/VCP-mediated ubiquitination-autophagy turnover and reverses Temozolomide-induced ER stress-tolerance in GBM cells.
    Li ZY; Zhang C; Zhang Y; Chen L; Chen BD; Li QZ; Zhang XJ; Li WP
    Cancer Lett; 2017 Apr; 391():89-99. PubMed ID: 28131906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of HDAC6 in ischaemia and reperfusion-induced rat retinal injury.
    Yuan H; Li H; Yu P; Fan Q; Zhang X; Huang W; Shen J; Cui Y; Zhou W
    BMC Ophthalmol; 2018 Nov; 18(1):300. PubMed ID: 30453928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of FGFR3- and MYC-dependent oncogenesis by tubacin: association with HDAC6-dependent and independent activities.
    Ota S; Zhou ZQ; Hurlin PJ
    Oncotarget; 2018 Jan; 9(3):3172-3187. PubMed ID: 29423038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-selective HDAC6 inhibitor promotes HDAC6 degradation following autophagy modulation and enhanced antitumor immunity in glioblastoma.
    Liu JR; Yu CW; Hung PY; Hsin LW; Chern JW
    Biochem Pharmacol; 2019 May; 163():458-471. PubMed ID: 30885763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of HDAC6 modifies tau inclusion body formation and impairs autophagic clearance.
    Leyk J; Goldbaum O; Noack M; Richter-Landsberg C
    J Mol Neurosci; 2015 Apr; 55(4):1031-46. PubMed ID: 25434725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The HDAC6 Inhibitor Tubacin Induces Release of CD133
    Chao OS; Chang TC; Di Bella MA; Alessandro R; Anzanello F; Rappa G; Goodman OB; Lorico A
    J Cell Biochem; 2017 Dec; 118(12):4414-4424. PubMed ID: 28452069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATP13A2 facilitates HDAC6 recruitment to lysosome to promote autophagosome-lysosome fusion.
    Wang R; Tan J; Chen T; Han H; Tian R; Tan Y; Wu Y; Cui J; Chen F; Li J; Lv L; Guan X; Shang S; Lu J; Zhang Z
    J Cell Biol; 2019 Jan; 218(1):267-284. PubMed ID: 30538141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The histone deacetylase inhibitor tubacin mitigates endothelial dysfunction by up-regulating the expression of endothelial nitric oxide synthase.
    Chen J; Zhang J; Shaik NF; Yi B; Wei X; Yang XF; Naik UP; Summer R; Yan G; Xu X; Sun J
    J Biol Chem; 2019 Dec; 294(51):19565-19576. PubMed ID: 31719145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HDAC6 inhibitor C1A modulates autophagy substrates in diverse cancer cells and induces cell death.
    Kaliszczak M; van Hechanova E; Li Y; Alsadah H; Parzych K; Auner HW; Aboagye EO
    Br J Cancer; 2018 Nov; 119(10):1278-1287. PubMed ID: 30318510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation.
    Haggarty SJ; Koeller KM; Wong JC; Grozinger CM; Schreiber SL
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4389-94. PubMed ID: 12677000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylase 6 inhibits influenza A virus release by downregulating the trafficking of viral components to the plasma membrane via its substrate, acetylated microtubules.
    Husain M; Cheung CY
    J Virol; 2014 Oct; 88(19):11229-39. PubMed ID: 25031336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tubacin, an HDAC6 Selective Inhibitor, Reduces the Replication of the Japanese Encephalitis Virus via the Decrease of Viral RNA Synthesis.
    Lu CY; Chang YC; Hua CH; Chuang C; Huang SH; Kung SH; Hour MJ; Lin CW
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28468311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylase 6 promotes growth of glioblastoma through the MKK7/JNK/c-Jun signaling pathway.
    Huang Z; Xia Y; Hu K; Zeng S; Wu L; Liu S; Zhi C; Lai M; Chen D; Xie L; Yuan Z
    J Neurochem; 2020 Jan; 152(2):221-234. PubMed ID: 31390677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of HDAC6 Activity Protects Against Endothelial Dysfunction and Atherogenesis
    Nomura Y; Nakano M; Woo Sung H; Han M; Pandey D
    Front Physiol; 2021; 12():675724. PubMed ID: 34220539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagy.
    Lee JY; Koga H; Kawaguchi Y; Tang W; Wong E; Gao YS; Pandey UB; Kaushik S; Tresse E; Lu J; Taylor JP; Cuervo AM; Yao TP
    EMBO J; 2010 Mar; 29(5):969-80. PubMed ID: 20075865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.